Gene Therapy Startup Lacerta Therapeutics Raises $30M in Equity Financing from Sarepta (MedCityNews)

A startup based out of the University of Florida developing viral vector-based gene therapies has drawn an equity investment from a larger, commercial-stage drugmaker.

Lacerta Therapeutics closed on the $30 million investment round, made by Cambridge, Massachusetts-based Sarepta Therapeutics, which gives Sarepta rights to multiple Lacerta central nervous system gene therapy programs. The announcement came from UF Innovate | Sid Martin Biotech, a biotechnology incubator at the University of Florida in Gainesville, where Lacerta is resident. Lacerta had previously raised $2.3 million in a Fast-track Phase I&II Small Business Technology Transfer from the National Cancer Institute.

Learn more about Gene Therapy Startup Lacerta Therapeutics Raises $30M in Equity Financing from Sarepta.